Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2022-05-12 2022-05-05
Drug Identification Number 00037915 00037915
Brand name DEXTROSE INJECTION USP DEXTROSE INJECTION USP
Common or Proper name Dextrose Injection USP Dextrose Injection USP
Company Name ICU MEDICAL CANADA INC ICU MEDICAL CANADA INC
Ingredients DEXTROSE DEXTROSE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 50 mL (4:1) 50 mL (4:1)
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-05-30 2022-05-23
Actual start date
Estimated end date 2022-06-17 2022-06-06
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments